ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2022

Chk1 Inhibition Ameliorates Alzheimer's Disease Pathogenesis and Cognitive Dysfunction Through CIP2A/PP2A Signaling.

Wenting Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.